(Q57560635)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27226155%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

title

Stem cells: The cancer's gone, but did chemotherapy damage your heart? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27226155%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27226155%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Christine Mummery

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27226155%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

2

Christine L. Mummery

0 references

language of work or name

English

0 references

publication date

26 May 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27226155%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Cardiology

2 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27226155%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27226155%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27226155%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

page(s)

383-384

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27226155%20AND%20SRC:MED&resulttype=core&format=json

Decline in the use of anthracyclines for breast cancer

2 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.88

Catching broken hearts: pre-clinical detection of doxorubicin and trastuzumab mediated cardiac dysfunction in the breast cancer setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.88

Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.88

Genetic background drives transcriptional variation in human induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.88

Systems biology approaches to adverse drug effects: the example of cardio-oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.88

A new initiative on precision medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.88

Immaturity of human stem-cell-derived cardiomyocytes in culture: fatal flaw or soluble problem?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.88

New signal transduction paradigms in anthracycline-induced cardiotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.88

Doxorubicin-induced cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.88

31 March 2020

Identifiers

DOI

10.1038/NRCARDIO.2016.88

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27226155%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

1 reference